What is the current size and annual growth rate of the cannabis use disorder market?
The cannabis use disorder market size has grown strongly in recent years. It will grow from $1.53 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the legalization and decriminalization of cannabis, rising public awareness of mental health and addiction, the growth of cannabis research and clinical studies, advances in behavioral therapy and addiction treatment, and increasing accessibility to treatment through digital health platforms.
The cannabis use disorder market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to expanding cannabis legalization and regulation, increasing mental health awareness and integrated care models, advances in pharmacological treatments and FDA approvals, the rise of digital therapeutics and telehealth services, and increased investment in research and evidence-based treatments. Major trends in the forecast period include digital and mobile health interventions, emerging studies suggesting psilocybin-assisted therapy, advancements in treatment options, adoption of personalized medicine, and advancements in biotechnology.
Get Your Free Sample of The Global Cannabis Use Disorder Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21126&type=smp
Which major factors have contributed to the expansion of the cannabis use disorder market?
The increasing awareness and diagnosis of cannabis addiction is expected to propel the growth of the cannabis use disorder market going forward. Awareness and diagnosis of cannabis addiction involve educating the public, healthcare professionals, and individuals about the signs, symptoms, and risks of cannabis use disorder (CUD). Increasing awareness and diagnosis of cannabis addiction rise due to several factors, such as increased cannabis legalization & availability and growing scientific & medical recognition. Cannabis use disorder treatment offers a structured approach to managing withdrawal symptoms, reducing cravings, and addressing underlying psychological factors, directly supports the diagnosis of cannabis addiction by providing clinical evidence of dependency patterns, reinforcing the severity of the disorder, and guiding the appropriate level of intervention based on the individual’s specific needs. For instance, in December 2023, according to the Office for Health Improvement and Disparities, a UK-based government department, the number of people seeking treatment for cannabis-related issues has risen by 2% this year, from 28,263 in 2021 to 28,845 in 2022. Therefore, increasing awareness and diagnosis of cannabis addiction is driving the growth of the cannabis use disorder market.
How is the cannabis use disorder market segmented?
The cannabis use disorder market covered in this report is segmented –
1) By Treatment: Pharmacotherapy, Behavioral Therapies
2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual
3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings
Subsegments:
1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Antipsychotics, Benzodiazepines
2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report
Who are the top competitors in the cannabis use disorder market?
Major companies operating in the cannabis use disorder market are Lyra Health Inc., Pyramid Healthcare Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam’s Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral Healthcare, GreeneStone
Which key trends are expected to influence the cannabis use disorder market in the coming years?
Major companies in the cannabis use disorder market are focusing on developing an advanced substance use management solution to provide personalized care for individuals struggling with cannabis addiction. A substance use management solution is a holistic system aimed at preventing, treating, and managing substance use disorders, helping individuals overcome dependency on substances like cannabis. It focuses on long-term recovery, relapse prevention, and enhancing overall well-being. For instance, in April 2024, Pelago, a US-based virtual clinic specializing in substance use management, introduced a cannabis use disorder (CUD) treatment program. The program aims to address the rising rates of CUD in the U.S., where nearly 18 million adults are affected. Pelago’s approach includes educating individuals about cannabis use and providing access to evidence-based care, such as cognitive behavioral therapy and motivational enhancement therapy. The program also supports adolescents aged 15-17 years old, focusing on abstinence-based goals.
Which regional trends are influencing the cannabis use disorder market, and which area dominates the industry?
North America was the largest region in the cannabis use disorder market in 2024. The regions covered in the cannabis use disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cannabis Use Disorder Market Report 2025 Offer?
The cannabis use disorder market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cannabis use disorder (CUD) refers to a condition characterized by the problematic or excessive use of cannabis, leading to significant impairment or distress. It is classified as a type of substance use disorder and occurs when an individual is unable to control or reduce their cannabis consumption despite negative consequences.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21126
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
